Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Parkinsonism & Related Disorders
|
January 10, 2025
The α-synuclein seed amplification assay: Interpreting a test of Parkinson's pathology
Alberto J Espay, Andrew J Lees, Francisco Cardoso, et al.
International Journal of Molecular Sciences
|
July 24, 2021
Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based Nosology
Luca Marsili, Jennifer Sharma, Alberto J Espay, et al.
Journal of Alzheimer'S Disease : JAD
|
September 19, 2022
High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations
Andrea Sturchio, Alok K Dwivedi, Tarja Malm, et al.
Orphanet Journal of Rare Diseases
|
October 29, 2025
Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes
Sebile Kilavuz, Kerri-Lee Wallom, Ana Catarina Gomes Almeida Augusto Caçote, et al.
Orphanet Journal of Rare Diseases
|
November 18, 2025
Correction: Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes
Sebile Kilavuz, Kerri-Lee Wallom, Ana Catarina Gomes Almeida Augusto Caçote, et al.
Parkinsonism & Related Disorders
|
May 8, 2021
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
Andrea Pilotto, Alberto Imarisio, Francesca Conforti, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
October 21, 2020
The odyssey of complex neurogenetic disorders: From undetermined to positive
Valeria Salinas, Patricia Vega, Luca Marsili, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 10, 2014
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs
Emilio Portaccio, Angelo Ghezzi, Bahia Hakiki, et al.
ACS Chemical Neuroscience
|
November 7, 2024
SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF Resulting in Drastic Soluble Protein Depletion
Wanda Christ, Sebastian Kapell, Michal J Sobkowiak, et al.
BMC Neurology
|
June 3, 2014
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study
Chiara Pecori, Marta Giannini, Emilio Portaccio, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Parkinsonism & Related Disorders
|
January 10, 2025
The α-synuclein seed amplification assay: Interpreting a test of Parkinson's pathology
Alberto J Espay, Andrew J Lees, Francisco Cardoso, et al.
International Journal of Molecular Sciences
|
July 24, 2021
Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based Nosology
Luca Marsili, Jennifer Sharma, Alberto J Espay, et al.
Journal of Alzheimer'S Disease : JAD
|
September 19, 2022
High Soluble Amyloid-β42 Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer's Disease-Causing Mutations
Andrea Sturchio, Alok K Dwivedi, Tarja Malm, et al.
Orphanet Journal of Rare Diseases
|
October 29, 2025
Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes
Sebile Kilavuz, Kerri-Lee Wallom, Ana Catarina Gomes Almeida Augusto Caçote, et al.
Orphanet Journal of Rare Diseases
|
November 18, 2025
Correction: Glycoprotein non-metastatic melanoma protein B is a biomarker of inflammation in individuals with Gaucher disease: relationship to clinico-pathological subtypes
Sebile Kilavuz, Kerri-Lee Wallom, Ana Catarina Gomes Almeida Augusto Caçote, et al.
Parkinsonism & Related Disorders
|
May 8, 2021
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
Andrea Pilotto, Alberto Imarisio, Francesca Conforti, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
October 21, 2020
The odyssey of complex neurogenetic disorders: From undetermined to positive
Valeria Salinas, Patricia Vega, Luca Marsili, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 10, 2014
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs
Emilio Portaccio, Angelo Ghezzi, Bahia Hakiki, et al.
ACS Chemical Neuroscience
|
November 7, 2024
SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF Resulting in Drastic Soluble Protein Depletion
Wanda Christ, Sebastian Kapell, Michal J Sobkowiak, et al.
BMC Neurology
|
June 3, 2014
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study
Chiara Pecori, Marta Giannini, Emilio Portaccio, et al.
Page
of 6